298 related articles for article (PubMed ID: 9113728)
21. Bispecific monoclonal antibodies to human interleukin 2 and horseradish peroxidase.
Stratieva-Taneeva PA; Khaidukov SV; Kovalenko VA; Nazimov IV; Samokhvalova LV; Nesmeyanov VA
Hybridoma; 1993 Jun; 12(3):271-84. PubMed ID: 8359822
[TBL] [Abstract][Full Text] [Related]
22. [A new approach to the design of hybrid hybridomas based on the use of an actinomycin D-resistant line of murine myeloma].
Massino IuS; Kizim EA; Dmitriev AD
Biull Eksp Biol Med; 1991 Nov; 112(11):511-4. PubMed ID: 1687361
[TBL] [Abstract][Full Text] [Related]
23. Binding properties of monoclonal anti-IgG antibodies: analysis of binding curves in monoclonal antibody systems.
Jacobsen C; Steensgaard J
Immunology; 1984 Mar; 51(3):423-30. PubMed ID: 6698574
[TBL] [Abstract][Full Text] [Related]
24. Monospecific and bispecific antibodies against E. coli O157 for diagnostics.
Guttikonda S; Tang XL; Yang BM; Armstrong GD; Suresh MR
J Immunol Methods; 2007 Oct; 327(1-2):1-9. PubMed ID: 17804009
[TBL] [Abstract][Full Text] [Related]
25. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
[TBL] [Abstract][Full Text] [Related]
26. Preparation and biomedical applications of bispecific antibodies.
Paulus H
Behring Inst Mitt; 1985 Dec; (78):118-32. PubMed ID: 3833240
[TBL] [Abstract][Full Text] [Related]
27. Bispecific antibody-producing hybrid hybridoma and its use in one-step immunoassays for human lymphotoxin.
Tada H; Toyoda Y; Iwasa S
Hybridoma; 1989 Feb; 8(1):73-83. PubMed ID: 2647617
[TBL] [Abstract][Full Text] [Related]
28. Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting.
Gu J; Ghayur T
Methods Enzymol; 2012; 502():25-41. PubMed ID: 22208980
[TBL] [Abstract][Full Text] [Related]
29. Bispecific antibody-producing hybrid hybridomas selected by a fluorescence activated cell sorter.
Karawajew L; Micheel B; Behrsing O; Gaestel M
J Immunol Methods; 1987 Feb; 96(2):265-70. PubMed ID: 2433353
[TBL] [Abstract][Full Text] [Related]
30. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
Biburger M; Weth R; Wels WS
J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
[TBL] [Abstract][Full Text] [Related]
31. Humanization of an anti-human IL-6 mouse monoclonal antibody glycosylated in its heavy chain variable region.
Sato K; Ohtomo T; Hirata Y; Saito H; Matsuura T; Akimoto T; Akamatsu K; Koishihara Y; Ohsugi Y; Tsuchiya M
Hum Antibodies Hybridomas; 1996; 7(4):175-83. PubMed ID: 9140729
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal IgG3 (kappa) antibodies against murine Thy-1.2 antigen produced by murine hybridomas. Differences in the specificity of the antigen binding site and in the structure of the hinge region.
Zikán J; Dráber P; Vojtísková M
Folia Biol (Praha); 1982; 28(6):377-94. PubMed ID: 6186535
[TBL] [Abstract][Full Text] [Related]
33. Development of a trispecific antibody conjugate that directs two distinct tumor-associated antigens to CD64 on myeloid effector cells.
Somasundaram C; Sundarapandiyan K; Keler T; Deo YM; Graziano RF
Hum Antibodies; 1999; 9(1):47-54. PubMed ID: 10331185
[TBL] [Abstract][Full Text] [Related]
34. TNT detection using llama antibodies and a two-step competitive fluid array immunoassay.
Anderson GP; Goldman ER
J Immunol Methods; 2008 Nov; 339(1):47-54. PubMed ID: 18755196
[TBL] [Abstract][Full Text] [Related]
35. Isolation and characterization of a monoclonal anti-quadruplex DNA antibody from autoimmune "viable motheaten" mice.
Brown BA; Li Y; Brown JC; Hardin CC; Roberts JF; Pelsue SC; Shultz LD
Biochemistry; 1998 Nov; 37(46):16325-37. PubMed ID: 9819225
[TBL] [Abstract][Full Text] [Related]
36. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E
Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794
[TBL] [Abstract][Full Text] [Related]
37. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
[TBL] [Abstract][Full Text] [Related]
38. Production of a bi-specific monoclonal antibody recognizing mouse kappa light chains and horseradish peroxidase. Applications in immunoassays.
Kenigsberg RL; Cuello AC
Histochemistry; 1990; 95(2):155-63. PubMed ID: 2127927
[TBL] [Abstract][Full Text] [Related]
39. Preparation of antibody against horseradish peroxidase using hybridoma technology.
Asadi A; Pourfathollah AA; Mahdavi M; Eftekharian MM; Moazzeni SM
Hum Antibodies; 2008; 17(3-4):73-8. PubMed ID: 19029664
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies to human insulin and their antigen binding behaviour.
Ziegler M; Dietz H; Keilacker H; Witt S; Ziegler B
Biomed Biochim Acta; 1984; 43(5):695-701. PubMed ID: 6383372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
